Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Letai

Showing results (41-50 of 182) with videos related to

Pageof 19
Sort By:
Leukemia & Lymphoma|April 26, 2013
Overcoming stroma-mediated treatment resistance in chronic lymphocytic leukemia through BCL-2 inhibitionMatthew S Davids, Anthony Letai, Jennifer R Brown
Trends in Cell Biology|September 25, 2013
Mitochondria: gatekeepers of response to chemotherapyKristopher A Sarosiek, Triona Ni Chonghaile, Anthony Letai
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Heightened mitochondrial priming is the basis for apoptotic hypersensitivity of CD4+ CD8+ thymocytesJeremy A Ryan, Joslyn K Brunelle, Anthony Letai
Biological Chemistry|February 25, 2016
iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometryJeremy Ryan, Joan Montero, James Rocco, et al.
Blood|March 4, 2010
Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1Derek Yecies, Nicole E Carlson, Jing Deng, et al.
Cancer Cell|September 24, 2004
Antiapoptotic BCL-2 is required for maintenance of a model leukemiaAnthony Letai, Mia D Sorcinelli, Caroline Beard, et al.
ACS Chemical Biology|February 9, 2016
Rapid Optimization of Mcl-1 Inhibitors using Stapled Peptide Libraries Including Non-Natural Side ChainsRaheleh Rezaei Araghi, Jeremy A Ryan, Anthony Letai, et al.
Cell|April 21, 2022
Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosisRongqing Pan, Jeremy Ryan, Deng Pan, et al.
Cell Death & Disease|July 28, 2021
Dynamic BH3 profiling identifies active BH3 mimetic combinations in non-small cell lung cancerDanielle S Potter, Ruochen Du, Patrick Bhola, et al.
Nature Reviews. Cancer|November 6, 2015
Precision medicine for cancer with next-generation functional diagnosticsAdam A Friedman, Anthony Letai, David E Fisher, et al.
Pageof 19

Showing results (41-50 of 182) with videos related to

Sort By:
Pageof 19
Leukemia & Lymphoma|April 26, 2013
Overcoming stroma-mediated treatment resistance in chronic lymphocytic leukemia through BCL-2 inhibitionMatthew S Davids, Anthony Letai, Jennifer R Brown
Trends in Cell Biology|September 25, 2013
Mitochondria: gatekeepers of response to chemotherapyKristopher A Sarosiek, Triona Ni Chonghaile, Anthony Letai
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Heightened mitochondrial priming is the basis for apoptotic hypersensitivity of CD4+ CD8+ thymocytesJeremy A Ryan, Joslyn K Brunelle, Anthony Letai
Biological Chemistry|February 25, 2016
iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometryJeremy Ryan, Joan Montero, James Rocco, et al.
Blood|March 4, 2010
Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1Derek Yecies, Nicole E Carlson, Jing Deng, et al.
Cancer Cell|September 24, 2004
Antiapoptotic BCL-2 is required for maintenance of a model leukemiaAnthony Letai, Mia D Sorcinelli, Caroline Beard, et al.
ACS Chemical Biology|February 9, 2016
Rapid Optimization of Mcl-1 Inhibitors using Stapled Peptide Libraries Including Non-Natural Side ChainsRaheleh Rezaei Araghi, Jeremy A Ryan, Anthony Letai, et al.
Cell|April 21, 2022
Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosisRongqing Pan, Jeremy Ryan, Deng Pan, et al.
Cell Death & Disease|July 28, 2021
Dynamic BH3 profiling identifies active BH3 mimetic combinations in non-small cell lung cancerDanielle S Potter, Ruochen Du, Patrick Bhola, et al.
Nature Reviews. Cancer|November 6, 2015
Precision medicine for cancer with next-generation functional diagnosticsAdam A Friedman, Anthony Letai, David E Fisher, et al.
Pageof 19